Busting 5 common myths about Pneumococcal Pneumonia

Pneumonia Awareness Week (July 2 – 8, 2012) This year’s theme for Pneumonia Awareness Week is Preventing Pneumococcal Pneumonia. Pneumococcal pneumonia is an often fatal lung infection caused by the bacteria Streptococcus pneumoniae, responsible for more deaths worldwide than any other single bacteria. This week, experts and patients are joining forces to heighten community awareness…

Read More

A Royal Honour – Will Delaat named on Queen’s Birthday Honours List

VIVA! Communications wishes to congratulate Will Delaat, current director of the Fragile X Association of Australia (FXAA), Pharmaxis and EnGenelC, who was named today in the Queen’s Birthday Honours List. Mr Delaat was honoured for ‘his service to the pharmaceutical industry through roles with professional organisations, to the development of medicines policy and reform, and to…

Read More

Dr John Skerrit appointed as new head of TGA

VIVA! Communications welcomes The Commonwealth Department of Health and Ageing’s (DoHA) appointment of Dr John Skerritt as the new National Manager of the Therapeutic Goods Administration (TGA), effective at the end of May. The TGA is the national body responsible for regulating therapeutic goods including medicines, medical devices, blood and blood products. According to the Secretary…

Read More

Originator manufacturers bracing for further PBS price cuts

The ongoing price disclosure system brokered by Medicines Australia and the Government will see another 13 medicines attract significant price cuts ranging from 11 to 77 per cent from August 1 this year. The medication price cuts are in addition to the broadbrush $1.9 billion in PBS savings that constitute the Memorandum of Understanding (MoU)…

Read More